Royal Bank of Canada lifted its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 14.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,831,624 shares of the medical research company’s stock after acquiring an additional 751,947 shares during the period. […]